Revised forecast
Fiscal year ended February 2026 · Full yearPrevious forecast published 8 January 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Recognition of extraordinary gains associated with the sale of investment securities and the transfer of shares in an equity-method affiliate, as well as a decrease in deferred income taxes resulting from the recognition of impairment losses.
Impairment losses (a factor contributing to the decrease in deferred income taxes); amount: Not disclosed
| Item | Details |
|---|---|
| Net Sales | 814,000 Millions of yen → 814,260 Millions of yen（+0.0%） |
| Operating profit | 10,600 Millions of yen → 11,217 Millions of yen（+5.8%） |
| Ordinary income | 11,800 Millions of yen → 12,527 Millions of yen（+6.2%） |
| Profit attributable to owners of the parent | 5,700 Millions of yen → 8,176 Millions of yen（+43.4%） |
| Net income per share | 65.78 yen → 94.36 yen |
| Fiscal Period Covered | Fiscal year ended February 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 8 January 2026 |
| Previous-period results | Operating revenue: ¥808,928 million; operating profit: ¥12,953 million; ordinary profit: ¥14,315 million; net income attributable to owners of the parent: ¥3,818 million; earnings per share: ¥44.06 (fiscal year ended February 2025) |
| Reason for the revision | Recognition of extraordinary gains associated with the sale of investment securities and the transfer of shares in an equity-method affiliate, as well as a decrease in deferred income taxes resulting from the recognition of impairment losses. |
| Details and amount of extraordinary loss | Impairment losses (a factor contributing to the decrease in deferred income taxes); amount: Not disclosed |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Recognition of extraordinary gains associated with the sale of investment securities and the transfer of shares in an equity-method affiliate, as well as a decrease in deferred income taxes resulting from the recognition of impairment losses.